• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血钾心脏停搏期间心肌保护的机制:晶体红细胞溶液与高铁血红蛋白溶液的比较

Mechanism of myocardial protection during blood-potassium cardioplegia: a comparison of crystalloid red cell and methemoglobin solutions.

作者信息

Bing O H, LaRaia P J, Franklin A, Stoughton J, Weintraub R M

出版信息

Circulation. 1984 Sep;70(3 Pt 2):I84-90.

PMID:6744572
Abstract

The mechanism of myocardial protection provided by red blood cells was studied with a preparation of isolated, blood-perfused dog heart. Myocardial function, metabolism, and high-energy phosphate stores were determined before and at the end of cardioplegic arrest and after reperfusion. Cardioplegic solutions containing NaCl, KCl, and dextran (crystalloid; C) were compared, at 27 degrees C, with an identical solution containing 20% washed red cells (R) and a third solution in which the red cells were treated with 0.02M NaNO2, resulting in methemoglobin (M) formation or red cells able to buffer pH but unable to transport oxygen. Solutions were delivered at 15 min intervals during 2 hr of arrest and coronary effluent pH, PCO2, and lactate were measured. Both R and M solutions prevented the increases in effluent PCO2 and decreases observed in pH with C. On the other hand, mechanical, metabolic, and high-energy phosphate determinations revealed that marked protection was provided by R but not by M or C. Thus, myocardial protection provided by R at 27 degrees C is not the result of buffering but appears to be primarily the result of oxygen delivery by the red cells to the myocardium.

摘要

利用离体血液灌注犬心标本研究了红细胞提供心肌保护的机制。在心脏停搏前、停搏结束时及再灌注后测定心肌功能、代谢及高能磷酸储存。将含氯化钠、氯化钾和右旋糖酐的心脏停搏液(晶体液;C)在27℃下与含20%洗涤红细胞的相同溶液(R)以及第三种溶液进行比较,在第三种溶液中红细胞用0.02M亚硝酸钠处理,导致高铁血红蛋白(M)形成或红细胞能够缓冲pH值但不能运输氧气。在停搏2小时期间每隔15分钟给予溶液,并测量冠状动脉流出液的pH值、PCO₂和乳酸。R溶液和M溶液均可防止流出液PCO₂升高以及C溶液中观察到的pH值降低。另一方面,机械、代谢和高能磷酸测定表明,R溶液提供了显著的保护作用,而M溶液和C溶液则没有。因此,27℃下R溶液提供的心肌保护不是缓冲作用的结果,而似乎主要是红细胞向心肌输送氧气的结果。

相似文献

1
Mechanism of myocardial protection during blood-potassium cardioplegia: a comparison of crystalloid red cell and methemoglobin solutions.血钾心脏停搏期间心肌保护的机制:晶体红细胞溶液与高铁血红蛋白溶液的比较
Circulation. 1984 Sep;70(3 Pt 2):I84-90.
2
Independent protection provided by red blood cells during cardioplegia.心脏停搏期间红细胞提供的独立保护作用。
Circulation. 1982 Aug;66(2 Pt 2):I81-4.
3
Enhanced myocardial protection during ischemic arrest. Oxygenation of a crystalloid cardioplegic solution.缺血性停搏期间增强心肌保护。晶体心脏停搏液的氧合。
J Thorac Cardiovasc Surg. 1983 May;85(5):769-80.
4
Myocardial recovery after hypothermic arrest: a comparison of oxygenated crystalloid to blood cardioplegia. The role of calcium.
Circulation. 1985 Sep;72(3 Pt 2):II241-53.
5
Protein kinase C isoform-dependent myocardial protection by ischemic preconditioning and potassium cardioplegia.蛋白激酶C亚型依赖性的缺血预处理和钾停搏心肌保护作用
J Thorac Cardiovasc Surg. 2001 Jan;121(1):137-48. doi: 10.1067/mtc.2001.111210.
6
The metabolic consequences of blood and crystalloid cardioplegia.血液和晶体心脏停搏液的代谢后果。
Circulation. 1981 Aug;64(2 Pt 2):II67-74.
7
Cardioprotective effects of normothermic reperfusion with oxygenated potassium cardioplegia: a possible mechanism.含氧量钾停搏液常温再灌注的心脏保护作用:一种可能的机制。
Interact Cardiovasc Thorac Surg. 2009 Oct;9(4):598-604. doi: 10.1510/icvts.2008.201277. Epub 2009 Jul 7.
8
Normocalcemic blood or crystalloid cardioplegia provides better neonatal myocardial protection than does low-calcium cardioplegia.正常血钙血液或晶体心脏停搏液比低钙心脏停搏液能提供更好的新生儿心肌保护。
J Thorac Cardiovasc Surg. 1993 Feb;105(2):201-6.
9
Superiority of perfluorocarbon cardioplegia over blood or crystalloid cardioplegia.
Circulation. 1981 Aug;64(2 Pt 2):II75-80.
10
Comparison of the effect of blood cardioplegia to crystalloid cardioplegia on myocardial contractility in man.血液停搏液与晶体停搏液对人体心肌收缩力影响的比较。
J Thorac Cardiovasc Surg. 1980 Nov;80(5):647-55.